Name | [(3S,10R,13S)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
---|---|
Synonyms |
CX1340
Androsta-5,15-diene-16-carboxaldehyde, 3-(acetyloxy)-17-chloro-, (3β)- (3β)-17-Chloro-16-formylandrosta-5,15-dien-3-yl acetate 3| cent-ACETOXY-17-CHLORO-16-FORMYLANDROSTA-5,16-DIENE Androsta-5,16-diene-16-carboxaldehyde, 3-(acetyloxy)-17-chloro-, (3β)- (3β)-17-Chloro-16-formylandrosta-5,16-dien-3-yl acetate |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 484.1±45.0 °C at 760 mmHg |
Molecular Formula | C22H29ClO3 |
Molecular Weight | 376.917 |
Flash Point | 165.1±27.7 °C |
Exact Mass | 376.180511 |
PSA | 43.37000 |
LogP | 4.99 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.558 |
~79% 1865-56-1 |
Literature: BIOMARIN PHARMACEUTICAL INC.; CHU, Daniel; WANG, Bing; YE, Tao Patent: WO2012/83112 A2, 2012 ; Location in patent: Page/Page column 181 ; WO 2012/083112 A2 |
~% 1865-56-1 |
Literature: Zhang, Bao-Le; Zhang, En; Pang, Lu-Ping; Song, Li-Xing; Li, Ya-Fei; Yu, Bin; Liu, Hong-Min Steroids, 2013 , vol. 78, # 12-13 p. 1200 - 1208 |